Insulin Degludec (rDNA Origin) Injection Drug Interactions

Brand name
  • Tresiba
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated Details about this page

About Insulin Degludec (rDNA Origin) Injection

Insulin degludec is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood).

Read the full Insulin Degludec (rDNA Origin) Injection drug information page 

The Bottom Line on Insulin Degludec (rDNA Origin) Injection

Insulin degludec is a long-acting insulin that helps your body manage blood sugar when it can't make enough insulin or doesn't use it well, whether you have type 1 or type 2 diabetes.

It has more documented interactions than almost any other medicine, and about half are rated serious. Most involve blood sugar swinging off course. Metformin is one to know, since taking it alongside this insulin can raise the chance of low blood sugar, and that pairing is rated major. The best habit is keeping one up-to-date list of everything you take, supplements included, and showing it whenever something changes.

From the HelloPharmacist Editorial Team Written with AI from this page's interaction records · How we build these pages · How we use AI · Our editorial policy

Check Insulin Degludec (rDNA Origin) Injection Against Another Drug or Supplement

Type a drug, a brand name or a supplement. We check it against every documented insulin degludec (rDNA origin) injection interaction, supplements and herbs included.

    What Could Happen When Insulin Degludec (rDNA Origin) Injection Interacts

    What the 166 documented insulin degludec (rDNA origin) injection interaction records say could happen, grouped by the problem each one names. Tap a bar to see those drugs.

    This chart covers drug interactions only. Interactions with supplements and herbs are studied far less, so they are not counted here; they have their own pages on this site. One interaction can name more than one problem, so the numbers add up to more than 166.

    Insulin Degludec (rDNA Origin) Injection Interactions by Severity

    Major

    How Drug Interactions Work New to drug interactions? Six short figures, about a minute, show what can happen when Insulin Degludec (rDNA Origin) Injection meets another medicine: a level that rises or falls, or effects that add up. See how it works 

    Look Up Another Drug

    Still Have Questions About Insulin Degludec (rDNA Origin) Injection?

    Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

    About This Library

    Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

    What Each Rating Means

    Severity Levels

    • Contraindicated These should generally not be used together.
    • Major Potentially serious — often needs a change or close monitoring.
    • Moderate Can be significant — usually manageable with monitoring.
    • Minor Usually limited clinical impact.
    Back to the answer

    The References Behind Insulin Degludec (rDNA Origin) Injection’s Interactions

    The 217 sources our insulin degludec (rDNA origin) injection interaction records cite: clinical studies, case reports and FDA prescribing information. Each pair's page lists the ones it rests on, numbered in its text, and a source link is one we checked against PubMed or Crossref. How we check them →

    1. Product Information: TRESIBA(R) subcutaneous injection solution, insulin degludec subcutaneous injection solution. Novo Nordisk (per manufacturer), Plainsboro, NJ, 2015. DailyMed 
    2. Korytkowski MT, Muniyappa R, Antinori-Lent K, et al: Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2022; 107(8):2101-2128. PubMed 
    3. Product Information: TRESIBA(R) subcutaneous injection, insulin degludec subcutaneous injection. Novo Nordisk (per FDA), Plainsboro, NJ, 2016. DailyMed 
    4. Product Information: TRESIBA(R) subcutaneous injection, insulin degludec subcutaneous injection. Novo Nordisk Inc (per FDA), Plainsboro, NJ, 2022. DailyMed 
    5. Bohn B, Zimmermann A, Wagner C, et al: Real-life experience of patients starting insulin degludec. A multicenter analysis of 1064 subjects from the German/Austrian DPV registry. Diabetes Res Clin Pract 2017; 129:52-58. PubMed 
    6. Thalange N, Deeb L, Iotova V, et al: Insulin degludec in combination with bolus insulin aspart is safe and effective in children and adolescents with type 1 diabetes. Pediatr Diabetes 2015; 16(3):164-176. DOI 
    7. Marso SP, McGuire DK, Zinman B, et al: Efficacy and safety of degludec versus glargine in type 2 diabetes. N Engl J Med 2017; 377(8):723-732. PubMed 
    8. Mathieu C, Rodbard HW, Cariou B, et al: A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON). Diabetes Obes Metab 2014; 16(7):636-644.
    9. Product Information: TRESIBA(R) subcutaneous injection, insulin degludec subcutaneous injection. Novo Nordisk Inc (per FDA), Plainsboro, NJ, 2018. DailyMed 
    10. Product Information: TRESIBA(R) subcutaneous injection, insulin degludec subcutaneous injection. Novo Nordisk Inc (per FDA), Plainsboro, NJ, 2019. DailyMed 

    Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.